Neurocrine Biosciences
This role involves driving computational methodologies to design optimized compounds for drug discovery programs, ranging from early lead identification to late-stage optimization. The position requires serving as a subject matter expert in molecular discovery approaches like structure-based design, virtual screening, and machine learning while communicating results to facilitate decision-making. Candidates will independently lead advanced technology platforms and may provide training to junior staff within the San Diego site.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
9% above the average for this role
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Senior Scientist, Computational Chemistry
lifelancer
Post-doctoral Computational Chemist, Advanced Molecular Design
Eli Lilly and Company
AI Chemistry Leader
IFF
Senior Principal Research Scientist, Computational Chemistry
IDEAYA Biosciences, Inc.
Computational Chemistry Scientist
Roche
Director/Senior Director, Computational Chemistry
Flagship Pioneering, Inc.